Description
MG Medicals, Quality Assurance
CompositionEltrombopag 50 mg
SimilarityElbonix 50 mg 7s x 5,Revolade 50mg 7s x 2 (FR)
StorageRoom Temperature
MG Medicals, Briefing of Elbonix 50mg 28 Tablet
Uses of Elbonix 50mg 28 TabletEltrombopag is used for low platelet count due to ITP or HCV infection. It is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It??s also used to treat severe aplastic anemia.
Elbonix 50mg 28 Tablet side reactionsNausea, Diarrhoea, Upper respiratory tract infection, Vomiting, Increased liver enzymes, Muscle pain, Urinary tract infection
How to take Elbonix 50mg 28 TabletTake Eltrombopag on an empty stomach, either 1 hour before or 2 hours after meals.
How Elbonix 50mg 28 Tablet worksEltrombopag is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. Platelets help to reduce or prevent bleeding.
MG Medicals, More Suggestion
Suggestion for Elbonix 50mg 28 Tablet
- Take Eltrombopag at least 2 hours before or 4 hours after eating dairy products and calcium-fortified juices.
MG Medicals, Tips & Warnings
Alcohol
WEIGH RISKS VS BENEFITS
There is no adequate data. Please consult your doctor.
Pregnancy
WEIGH RISKS VS BENEFITS
There are no adequate and well-controlled studies of Eltrombopag use in pregnancy. In animal reproduction and developmental toxicity studies, there was evidence ofembryolethality and reduced fetal weights at maternally toxic doses. Eltrombopag should beused in pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.
Lactation
It is not known whether Eltrombopag is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Eltrombopag, a decision should be made whether to discontinue nursing or to discontinue Eltrombopag taking into account the importance of Eltrombopag to the mother.
Driving
There is no adequate data. Please consult your doctor.
Kidney
Hepatic impairment influences the exposure of Eltrombopag. Reduce the initial dose of Eltrombopag in patients with chronic ITP (adult and pediatric patients 6 years and older only) or severe aplastic anemia who also have hepatic impairment (Child-Pugh Class A, B, C). No dosage adjustment is necessary for patients with chronic hepatitis C and hepatic impairment.
Liver
No adjustment in the initial dose of Eltrombopag is needed for patients with renal impairment. Closely monitor patients with impaired renal function when administering Eltrombopag.
MG Medicals, If miss a dose
In case you miss a dose, take the next dose at the next time interval.
Disclaimer
The site and the information of MG Medicals (mgmedicals.com) are ONLY for reference purposes, and mgmedicals.com or MG Medicals or MG Medicals Pharmacy cannot be a replacement of professional medical advice, diagnosis, or treatment. MG Medicals request all visitors to obtain the advice of a physician or any qualified health provider with any questions they may have regarding a medical condition. Any prescription drugs, it??s only be sold with the approval of qualified doctors, specialists, or pharmacists.
